INVO BioScience News - INVO

Company Name	Stock Ticker Symbol	Market	Type
INVO BioScience Inc	INVO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0199	2.03%	1.00	19:59:47

Open Price	Low Price	High Price	Close Price	Prev Close
0.94	0.9081	1.09	0.98	0.9801

more quote information »

Recent News

Date	Time	Source	Heading
4/17/2024	10:25	APS	Micro Cap Massively Bid Up Before Opening Bell
4/16/2024	16:59	GLOBE	INVO Reports Fourth Quarter and Full Year 2023 Financial..
2/06/2024	10:24	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/01/2024	09:01	EDGAR2	Form 8-K - Current report
1/23/2024	08:00	GLOBE	NAYA Biosciences To Acquire Clinical Stage Gene Therapy..
1/17/2024	08:00	GLOBE	INVO Bioscience Files S-4 Registration and Preliminary Joint..
1/16/2024	17:29	EDGAR2	Form S-4 - Registration of securities, business combinations
1/10/2024	16:46	EDGAR2	Form 8-K/A - Current report: [Amend]
1/10/2024	16:05	EDGAR2	Form 8-K - Current report
1/03/2024	17:29	EDGAR2	Form 8-K - Current report
12/28/2023	17:04	EDGAR2	Form 424B7 - Prospectus [Rule 424(b)(7)]
12/28/2023	17:02	EDGAR2	Form 8-K - Current report
12/13/2023	17:08	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/13/2023	16:53	EDGAR2	Form 8-K - Current report
12/11/2023	08:00	PRNUS	NAYA Biosciences Announces Publication of New Data for its..
11/28/2023	17:18	EDGAR2	Form 8-K - Current report
11/28/2023	09:00	PRNUS	INVO Bioscience Regains Compliance with Nasdaq Minimum..
11/24/2023	13:08	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/20/2023	16:59	EDGAR2	Form 8-K - Current report
11/13/2023	16:10	EDGAR2	Form 8-K - Current report
11/13/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	16:01	PRNUS	INVO Reports Record Third Quarter 2023 Financial Results
11/13/2023	09:23	EDGAR2	Form SC TO-C - Written communication relating to an issuer..
11/13/2023	09:21	EDGAR2	Form 8-K - Current report
11/13/2023	09:12	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/10/2023	09:00	PRNUS	NAYA Biosciences and INVO Bioscience Announce Appointment of..
11/09/2023	16:40	PRNUS	INVO Bioscience Announces Commencement of Waiver..
10/27/2023	09:00	PRNUS	Free Registration Is Now Open For Tribe Public's CEO and Q&A..
10/26/2023	16:56	EDGAR2	Form 8-K - Current report
10/24/2023	17:10	EDGAR2	Form 8-K - Current report
10/23/2023	07:30	PRNUS	INVO Bioscience and NAYA Biosciences Announce Definitive..
10/16/2023	06:15	EDGAR2	Form 8-K - Current report
10/11/2023	09:00	PRNUS	INVO to Participate in the Lytham Partners Fall 2023..
10/05/2023	16:28	EDGAR2	Form 8-K - Current report
10/03/2023	17:24	EDGAR2	Form 8-K - Current report
10/02/2023	17:12	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
9/29/2023	17:26	EDGAR2	Form 8-K - Current report
9/29/2023	16:05	PRNUS	INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
9/28/2023	12:45	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
9/28/2023	12:30	PRNUS	INVO Reminds Shareholders to Cast Their Vote for Upcoming..
9/08/2023	16:34	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
9/01/2023	17:17	EDGAR2	Form 8-K - Current report
9/01/2023	09:55	EDGAR2	Form DEF 14A - Other definitive proxy statements
8/21/2023	16:33	EDGAR2	Form PRE 14A - Other preliminary proxy statements
8/14/2023	16:10	EDGAR2	Form 8-K - Current report
8/14/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:05	PRNUS	INVO Reports Second Quarter 2023 Financial Results
8/11/2023	16:18	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/11/2023	14:07	EDGAR2	Form 8-K - Current report
8/11/2023	08:00	PRNUS	INVO Closes Acquisition of Wisconsin Fertility Institute